Caseware UK (AP4) 2024.0.164 2024.0.164 2024-10-312024-10-31No description of principal activityfalsefalse2023-11-01true00true 02547912 2023-11-01 2024-10-31 02547912 2022-11-01 2023-10-31 02547912 2024-10-31 02547912 2023-10-31 02547912 c:Director1 2023-11-01 2024-10-31 02547912 c:Director2 2023-11-01 2024-10-31 02547912 c:RegisteredOffice 2023-11-01 2024-10-31 02547912 d:CurrentFinancialInstruments 2024-10-31 02547912 d:CurrentFinancialInstruments 2023-10-31 02547912 d:ShareCapital 2024-10-31 02547912 d:ShareCapital 2023-10-31 02547912 c:OrdinaryShareClass1 2023-11-01 2024-10-31 02547912 c:OrdinaryShareClass1 2023-10-31 02547912 c:EntityHasNeverTraded 2023-11-01 2024-10-31 02547912 c:FRS102 2023-11-01 2024-10-31 02547912 c:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 02547912 c:FullAccounts 2023-11-01 2024-10-31 02547912 c:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 02547912 e:PoundSterling 2023-11-01 2024-10-31 xbrli:shares iso4217:GBP xbrli:pure


Registered number: 02547912












AMERICAN DIAGNOSTIC CORPORATION LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024

 

AMERICAN DIAGNOSTIC CORPORATION LIMITED

CONTENTS



Page
Company information
 
1
Balance sheet
 
2
Notes to the financial statements
 
3


 

AMERICAN DIAGNOSTIC CORPORATION LIMITED
 
COMPANY INFORMATION


Directors
M Blitstein 
N Weingart 




Registered number
02547912



Registered office
74 Green Road

Fareham

Hampshire

PO14 2HE




Accountants
Blick Rothenberg Limited
Chartered Accountants

16 Great Queen Street

Covent Garden

London

WC2B 5AH




Page 1


 
REGISTERED NUMBER:02547912
AMERICAN DIAGNOSTIC CORPORATION LIMITED

BALANCE SHEET
AS AT 31 OCTOBER 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 3 
2
2

Total assets less current liabilities
  
 
 
2
 
 
2

  

Net assets
  
2
2


Capital and reserves
  

Called up share capital 
 4 
2
2

Total equity
  
2
2


For the year ended 31 October 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




N Weingart
Director

Date: 19 September 2025

The notes on page 3 form part of these financial statements.

Page 2

 

AMERICAN DIAGNOSTIC CORPORATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024

1.


General information

American Diagnostic Corporation Limited is a private company limited by shares incorporated in England and Wales. Its registered office is 74 Green Road, Fareham, Hampshire, PO14 2HE.
The financial statements are presented in Sterling (£).

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

  
2.2

Share capital

Ordinary shares are classified as equity.

 
2.3

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.


3.


Debtors

2024
2023
£
£


Called up share capital not paid
2
2



4.


Share capital

2024
2023
£
£
Shares classified as equity
 
Allotted, called up and unpaid



Enter number (2023 - 2) Ordinary shares of £1.00 each
2
2



5.


Parent undertaking and controlling party

The company's immediate and ultimate parent is ADC UK LLC whose registered office is 55 Commerce Drive, Hauppage, New York 11788-3931, United States of America. Consolidated financial statements at group level are not prepared. There is no ultimate controlling party.

Page 3